Arich Enterprise Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018
March 27, 2019 at 08:19 pm
Share
Arich Enterprise Co. Ltd. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was TWD 1,301.764 million compared to TWD 1,204.477 million a year ago. Operating income was TWD 46.410 million compared to TWD 2.739 million a year ago. Net income was TWD 50.280 million compared to TWD 5.187 million a year ago. Basic earnings per share was TWD 1.13 compared to TWD 0.12 a year ago. Diluted earnings per share was TWD 1.12 compared to TWD 0.12 a year ago.
Arich Enterprise Co., Ltd. is a Taiwan-based company principally engaged in the sales and marketing of pharmaceuticals, as well as the provision of the related logistics services. The Company is principally engaged in the sale and marketing of prescription drugs for gynaecology, obstetrics, urinary, derma and ophthalmology use; guideline drugs for hair breeding, intestines and stomach and smoking quit, as well as health consumer goods for oral health, daily consuming and beauty care, among others. The Company also provides distribution and logistics services for prescription drugs, guideline drugs, restriction drugs, cold chain drugs, clinical trial drugs and healthcare products, among others. The Company operates its business mainly within domestic market.
ARICH ENTERPRISE CO., LTD. 